SEMA3B and major depressive disorder: Increasing the levels of SEMA3B in the hippocampus or the lateral ventricles, improved CMS-induced depression-like behaviors and increased resilience to acute stress by increasing dendritic spine density in hippocampal neurons (Du et al., 2022).